Skyrizi 150 MG/ML penml
Ended Awarded Last action
- Contract number
- SPE2DR26F1GEM
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $30,949
Award facts
- Contract value 100% obligated
- $30,948.50 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $30,948.50 to AmerisourceBergen Drug Corp for the supply of SKYRIZI 150 MG/ML pen/mL, a biologic immunosuppressant medication used primarily to treat inflammatory skin conditions. This firm fixed-price, competitively awarded contract (with no set-aside designation) was issued on January 9, 2026, with an ultimate completion date of January 12, 2026, and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), valued at up to $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of medications and medical supplies to military healthcare systems worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and subsidiary of parent company Cencora, Inc., has demonstrated extensive capability in fulfilling federal medical procurement requirements through its federal contract portfolio. The company's contract awards with the Defense Logistics Agency and Defense Health Agency consistently involve firm fixed-price delivery orders for pharmaceutical products across multiple therapeutic domains, including specialty medications, vaccines, and medical devices. This particular delivery order represents routine pharmaceutical procurement through an established and proven contract vehicle supporting military healthcare operations globally.
Quick answers
Who was awarded contract SPE2DR26F1GEM?
SPE2DR26F1GEM was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 9, 2026.
How much is contract SPE2DR26F1GEM worth?
The government has obligated $30,949 on SPE2DR26F1GEM.
Is contract SPE2DR26F1GEM an order under another contract?
Yes. SPE2DR26F1GEM is a delivery order under SPE2DR25D2106, an indefinite delivery contract.
Was contract SPE2DR26F1GEM competed?
The extent of competition for SPE2DR26F1GEM was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award